2 of 10 LLC » Products and Services
2 of 10 LLC is a veteran owned Michigan company founded to develop and commercialize innovative concealed carry products for the professional law enforcement market. The company is also strongly positioned to capture a large segment of the growing civilian concealed carry market of over 7 million licensed consumers in the US. Traditional concealment holsters force the user to choose between concealment, accessibility and comfort. Pocket carry is a convenient alternative for smaller handguns but is limited by typical garment construction using lightweight, shallow pockets. Our patent-pending Constant Companion™ concealment system has the appearance of a typical pair of pants but contains an abrasion resistant, lint free front pocket that acts as a full sized universal holster; keeping the gun upright, secure and ready to draw. The pocket protects from perspiration and corrosion and incorporates a breathable 3D comfort layer. After dozens of prototypes and years of testing, 2 of 10 LLC is preparing to launch the Constant Companion™ clothing line in the fall, 2012. The Constant Companion™ is proudly manufactured in the United States to comply with agency procurement guidelines. 2 of 10 LLC is currently seeking capital to expand our product line and market.
AccuTherm Systems, Inc. » Medical Devices
AccuTherm Systems, Inc. (ATS) is a spinout of Accumed Systems, Inc. whose experienced management team and advisors have successfully commercialized several interventional cardiovascular products. ATS has developed the Thermal Sensing System (TSS), a coronary lesion-specific temperature sensing system, for use in diagnostic and percutaneous cardiovascular intervention (PCI) procedures. Thirteen patents have been created or licensed for measuring the temperature of coronary lesions. First-In-Man studies have been completed demonstrating ease of use and ability to accurately measure lesion temperature. ATS holds an approved IDE that will support both 510(k) and CE Mark approval. It is in the process of developing a smaller 6-F size version for application in radial or femoral PCI approach. Upon FDA approval (anticipated Q4 Year 2), initial sales will be to the pharmaceutical and device industries for research purposes generating $5MM in sales in Year 03. As treatment algorithms change to reflect the clinical need, the TSS potentially could be used in up to 60% of 3 million PCIs worldwide. The total market opportunity is >$200MM. It has received a commitment from Abbott Ventures, Inc. for $500K contingent upon receiving the balance of funds.
ActaTex, Inc. » Advanced Materials
ActaTex is a company formed in November of 2011 to manufacture and develop low-pressure nanofiber membranes. These materials can be included in the broader category of Technical Textiles, a $126 Bn market, and will be sold to manufacturers of filters and filtration systems as rolled goods. Industrial fabrics like Gore-Tex®, Tyvek®, Thinsulate™ and Reemay® are all +$1 billion examples of technical textile products. ActaTex enables high efficiency filtration media with a proven value proposition in strategic markets. Improved filtration performance will: 1) Improve pollutant removal for increased health and safety, 2) Reduce energy consumption in filtration applications by up to $5B in HVAC alone and 3) Increase filter life through superior mechanical filtration mechanisms. The founders have spent the past four years working together in the technical textile industry selling advanced manufacturing equipment for the industrial production of nanofiber membranes. Management’s work with multiple customers to develop advanced filtration membranes results in significant application knowledge and will enable ActaTex to launch with a strong roster of customer relationships leveraging development work already completed. ActaTex will provide market driven low-pressure membrane company rapidly accelerating market development by providing break-through materials in a supply chain friendly format.
Aegis Bleu » Products and Services
Aegis Bleu, LLC is the provider of the most comprehensive, accurate, and actionable physical infrastructure safety and security self-assessment software tools available. A homeland security and safety-consulting corporation, Aegis Bleu believes that safety and security can be improved utilizing objective software tools and analytics. Aegis Bleu seeks to continuously improve the safety and security of today’s critical infrastructures by utilizing our objective assessment tools, which any individual is capable of using, regardless of their education or experience. Aegis Bleu’s first software tool was Vulnerability Assessment Security Survey Tool (VASST). VASST is a mobile security vulnerability assessment tool that is customizable to meet any industry sector’s requirements and standards. The latest product created is Avert, which is a healthcare-specific safety vulnerability assessment tool that meets the industry’s standards for accreditation. Both products are the first tablet based security and safety vulnerability assessment tools that can reduce overall assessment time by as much as 80%. Aegis Bleu, LLC is committed to the continuous improvement of critical infrastructure protection from threats and hazards. The goal is to improve existing products and practices, using the latest technology and methods, to provide effective and efficient tools for all industry sectors.
Algal Scientific Corporation » Life Science
Algal Scientific uses algae to convert low cost nutrients into a unique compound, beta– 1,3 glucan that has been extensively researched due to its ability to boost the immune system within humans and animals. Our process yields more than a 50% cost reduction compared to the current wholesale world prices, and as a result opens up a potential $20B market in the animal nutrition industry, where usage today has been limited due to cost. Opportunistically, our process can be used to treat food grade process water from industries such as breweries and dairies. This process could save these industries millions of dollars, provide low or negative cost nutrients for our process, and absorb most of the capital costs for our production process. Our team includes scientists and engineers with expertise in algae and bio-chemical production, entrepreneurs experienced in taking high tech firms public, and a world-class group of advisors from academia and industry. We are optimizing and scaling up our pilot production to meet customer needs. We are expecting regulatory certifications in September 2012 and are conducting animal feed efficacy trials. We expect to be in commercial production before year-end 2012.
ArborWind, LLC » Alternative Energy
ArborWind is commercializing its patented vertical axis wind turbine technology. Our plan is to lead the small, and later medium wind turbine market, currently estimated to grow 35% for 2012 in North America alone. ArborWind’s superior design developed by a team of experienced automotive engineers is easy to manufacture, install, and maintain. The level of efficiency and expertise results in energy production costs of 9 cents /kWh or less based on extensive physical testing and computer simulations. Compared to the mainstream horizontal axis wind turbines on the market, ArborWind vertical axis wind turbines are omni-directional, resulting in over 20% improvement in wind energy conversion. Furthermore, blade design and manufacturing has been optimized to achieve over 30-year life. Five Beta customers have signed up to purchase the first product that is a 50 kW turbine (PT150) as their calculated ROI ranges from 16% to 28% based on current utility rates at their locations. The PT150 is a stand-alone product that will supply grid quality electricity to the end customer. ArborWind customers will make significant profit by utilizing its product and not worrying about escalating utility and fossil fuel based energy costs. See website for video of turbine in operation.
Biophotonic solutions » Next Generation Manufacturing
Biophotonic Solutions Inc. (BSI) is a leading laser-technology firm with global product sales exceeding $1.5M annually, up 30%+ each of the past three years. Its products “turbo charge” other firms’ laser systems, greatly enhancing the power and versatility of those systems. BSI has exclusive license to disruptive technology that unleashes latent capabilities of ultra-fast femto-second lasers. BSI’s position is heavily protected with 12 issued patents and many more pending. BSI’s products have been primarily used in the Scientific Instrument Market. However, a number of multi-billion dollar biomedical and defense markets are emerging for ultra-fast lasers including mass spectrometry, biomedical imaging, and corrective laser eye surgery. The dominant trend in ultrafast research is using pulses as short as possible –the core strength of BSI products. BSI’s vision is to drive the transition of ultrafast lasers from the Scientific Instrument Market, a sizable opportunity itself, into large, real-world applications. BSI anticipates much stronger growth ahead, projecting over $52M in sales by 2017. This growth takes only into account the Scientific Instrument Market. Entry into vertical markets will notably increase these projections (Biomedical Mass Spectrometry and Imaging/Cancer Detection are the first verticals planned).
BioSavita » Life Science
BioSavita is a biotechnology company focused on accelerating therapeutic antibody development for our partners. Antibodies are the newest pharmaceutical blockbusters with $56 billion in aggregate sales in 2011 growing at 13–15% CAGR to over $70B by 2015. BioSavita’s CEO has successfully led venture-backed as well as publicly traded biotech companies. BioSavita’s management team includes two of the top-licensing professionals for antibody expression platforms. The company has developed and validated its Twin Cassette™ yeast expression platform technology. BioSavita’s technology enables the manufacture of fully functional antibodies, single domain antibodies, and fusion proteins in secreted form. The company’s lead therapeutic programs are an anti-CD52 IgG monoclonal antibody (Campath® biosimilar) for multiple sclerosis, IL-15 muteins for cancer and secretory IgA antibody for C. difficile infection. These programs are available for out-licensing and co-development. BioSavita’s technology has been validated by peer-reviewed grants from NIH and by technology licensing agreements with five major pharmaceutical companies. For biopharma using the current expression methods available, BioSavita’s yeast platform has the potential to shorten the discovery phase for antibodies by 30%, and reduce the capital costs of manufacturing by 50%. The company licenses the platform to companies for an upfront fee and royalties.
Blaze Medical Devices LLC » Medical Devices
Blaze Medical Devices is a medical device development company focusing on improving the efficacy and safety of blood transfusions. Blood units differ in properties coming from donors and these differences, amplified by unavoidable storage, result in significant and unpredictable variability in transfusion outcomes. In the absence of quality metrics based on actual cell properties, a “first-in, first-out” approach is used up to the FDA allowed 42 days in storage. Blaze is developing a novel blood analyzer device based on a proprietary approach to determining the Red Blood Cell (RBC) membrane fragility, which would be the first such test capable to be used in a clinical context. This in-vitro test, will allow clinicians to establish the real-life quality of available blood thus predicting the effectiveness of blood transfusions. Blaze is developing a novel blood analyzer based on a proprietary approach to determining the RBC membrane fragility that would be the first such test capable to be used in a clinical context. This in-vitro test, will allow clinicians to establish the real-life quality of available blood thus predicting the effectiveness of blood transfusions. This technology can address the adverse reactions of RBC’s transfusions totaling over $17Billion in additional costs throughout the US healthcare system.
Blue Water Bioproducts » Advanced Materials
Blue Water Bioproducts (BWB) offers cost competitive, high performance polyurethane resins manufactured from an environmentally friendly and renewable material. BWB polyurethane resins use a renewable material called lignin. Lignin is a naturally occurring polymer in plants. Lignin is the glue that holds plant fibers together, and is a byproduct of the pulp and paper industry. The global pulp and paper industry annually produces 50 million tons of lignin. Currently, the inherent value of lignin is squandered by burning it for its heat value. The BWB proprietary and patent-pending process harnesses the chemical value of lignin. The resulting lignin-based polyurethane resins are over 80% carbon neutral, cost competitive with petroleum-based polyurethane resins, and meet or exceed performance characteristics such as tensile strength, flex modulus, R-value, and compressive strength when compared to petroleum-based polyurethane resins. BWB will be offered in the domestic polyurethane resin market, which uses over 7.6 billion lbs. of resin per year. Using its pilot production facility, BWB will produce a lignin polyurethane resin for several segments of the polyurethane industry. BWB will receive revenue from material production, and licensing its technology to larger capacity polyurethane manufacturers.
BREONICS » Medical Devices
BREONICS is commercializing a technology to solve the shortage of transplantable kidneys. The company’s “EMS” system will enable expansion of the donor pool to include hundreds of thousands of potential deceased donors who are never considered today. This technology has been developed over the last 15 years and is now entering clinical trials at the University of Michigan under a grant from NIH. Despite there being nearly 600,000 people in the United States with End Stage Renal Disease, a shortage of transplantable kidneys limits the number of kidney transplants to approximately 17,000 per year. Even with millions of deaths in the US every year from all causes, less than 11,000 kidneys are recovered from cadaveric donors, with the remainder coming from living donors. The reason for this is that current hypothermic preservation technologies limit the cadaveric donor pool to only those who die of “brain death”—a total pool that is less than 20,000 potential donors annually. The EMS system has the potential to increase the number of kidney transplants performed by up to 100,000 per year by enabling use of previously unrecoverable cadaveric kidneys from a much larger, currently untapped donor pool.
Brio Device, LLC » Medical Devices
Brio Device, LLC is an Ann Arbor, MI based early stage medical device company developing a series of airway management devices for clinicians who insert breathing tubes into the windpipe through the procedure known as intubation. Brio is an offshoot of the University of Michigan Medical Innovation Center. The company’s first product is a disposable guiding stylet designed to provide clinicians with improved control and tip articulation while the endotracheal tube is inserted. To date, the company has created prototypes that have been demonstrated by physicians and medical residents on simulation mannequins. Design for manufacturing has commenced and commercial revenue is anticipated with in 2013. Brio is in the R&D phase of follow-on products to suit the needs of emergency responders in this life-saving procedure of intubation. Software algorithms used to recognize structures in the airway anatomy are being developed. Devices integrating this software will have a graphical display screen and guidance feedback system showing the proper insertion pathway, similar to the visual effects found on video games. Brio’s products are designed to improve first-attempt success rates and reduce ramifications to patients from improper intubation (torn vocal cords, aspiration, even brain damage or death.
Civionics » Alternative Energy
For building owners and real-estate investment trusts that wish to monitor and control the cost of their utilities, Civionics offers a comprehensive wireless monitoring solution to sub-meter building utilities, perform real-time energy audits, and introduce control solutions for minimization of facility resource consumption without sacrificing inhabitant comfort. Civionics’s building energy management solution utilizes proprietary low-cost wireless sensors for monitoring utility usage (gas, water and electricity), environmental parameters, and occupant activity. Measurement data is analyzed to determine an equitable distribution of utility costs to tenants and alerting owners of opportunities for utility conservation. Furthermore, Civionics’s solution is capable of interfacing to legacy HVAC systems to locally control HVAC components for minimization of HVAC resource consumption without sacrificing occupant environmental preferences. Integral to Civionics’s solution is a proprietary database upon which Civionics analytics are executed in the cloud to perform comprehensive energy audits of a building including the prediction of utility demand. Demand prediction allows owners to select the most cost-effective pricing schedules with their utility providers. Civionics’s building energy management system also allows building owners to shed the risks associated with volatile utility costs by passing these costs equitably to tenants while reducing vacancy rates and driving net income higher.
CloudAccess.net » Information Technology
CloudAccess.net, LLC is an award-winning Internet hosting company with a variety of cloudbased business solutions. Since 2010, CloudAccess.net has been exclusive host for the demo trial of Joomla, a content management system that powers approximately 3% of the world’s websites. The company has optimized its resources to support Joomla, and thousands of users launch trial versions of Joomla through the CloudAccess.net platform every month. CloudAccess.net empowers users to create their own highly functional websites and has retained over 7,000 active clients including Barnes & Noble, K2 Sports and The Boston Children’s Hospital. CloudAccess.net, headquartered in Traverse City, Michigan, has experienced immense growth and currently has 33 employees with satellite offices in Cheboygan, Michigan; Szczecin, Poland; and Gujarat, India. CloudAccess.net has built an irreplaceable niche in the marketplace because of its relationship with Joomla, and the company is building upon that niche by diversifying product offerings. Recently investing into state-of the art server and storage technology, CloudAccess.net is expanding its cloud hosting products. These include enterprise-ready virtual private server environments and encrypted backup and disaster recovery plans. CloudAccess.net is currently looking to propel itself into the wide-open marketplace.
Coliant Corporation » Next Generation Manufacturing
By putting the “power” back in power sports vehicles, co-founders of Warren-based Coliant Corporation, John Swiatek, Dave Meerhaeghe, and Adam Bonislawski focus on a rider’s comfort, convenience and safety. Coliant designs, manufactures and distributes rugged electrical accessories that are intuitive and universally adaptable. Under the company’s Powerlet brand, Coliant developed its Rugged Electrix product line to withstand water, vibration, UV rays and oil/gas, meeting its own global compliance standards for electrical interface. Although focused initially on the motorcycle market, the Powerlet product line has applications in numerous industries and on various power sport vehicles. Powerlet has dealer and distribution outlets throughout the U.S., UK, Europe, Asia, and Australia providing support for the power outlets found on BMW, Triumph, KTM and Ducati motorcycles. Direct OEM customers include Polaris Industries, Indian Motorcycles, Motus and KTM North America. Coliant has raised capital from private investors, the FirstStepFund and the Preseed Fund.
Dynamic Intelligent Solutions, LLC » Next Generation Manufacturing
Dynamic Intelligent Solutions, LLC (DIS), provides dynamic testing and measurement solutions that enable companies to develop better products more affordably. They do this by utilizing optical, modular portable CMM equipment and data acquisition measurement software. DIS features a proprietary optical measurement process (ChamberCam) for monitoring the dimensional performance of a product during temperature and humidity changes throughout its normal duty cycle. DIS offers their customers measurement services and measurement equipment based on individual customer needs. DIS measurement services can also be deployed as a mobile system at a customer facility. DIS services are currently being offered to the automotive industry in SE Michigan and the agricultural industry nationally. The use of the DIS optical measurement techniques can be applied to similar industries where a defined product development process is used. These industries include military and defense products, aerospace and aircraft, recreational vehicle and consumer products.
Eco-Fueling » Advanced Transportation
ECO-Fueling, LLC of Saline, MI, has designed, built, road-tested, and delivered its first customer vehicle with a LOI of 300 more units, of a new fuel savings retrofit product. This new technology uses a renewable fuel (E85) that is directly injected into the intake manifold airflow of any diesel engine. Independent testing of this new technology has shown net increases in fuel economy of 15% and performance, while providing reductions of particulate matter (PM) by 50% and nitrous oxides (NOx) by 20%. All of these results directly influence net operational costs for a cash savings of as much as 15%. The average heavy-duty diesel truck uses approximately $100,000 of fuel per year. Our technology has to the potential of saving $15,000 per vehicle for the end user and replaces 15% of the diesel fuel with renewable E85. The net return on investment for a typical on road truck application of ECOIS is less than 190 days of continuous operation using diesel pricing at $4.07 per gallon. The initial target market is Midwest regional fleets. This will allow us to utilize fuel distributors as our channel partners and develop fleet data to support a national rollout.
Eco-Park/EWI LLC.» Next Generation Manufacturing
Eco-Park/EWI, LLC (EP/EWI) is a joint venture between Environmental Waste International Inc. (EWI), a publicly traded Canadian technology company, and Eco-Park Partners LLC, a 7-year-old Michigan-based clean technology development company. EWI’s Reverse Polymerization (RP) technology is a result of 19 years of ongoing R&D dedicated to a new scrap tire solution. RP directly addresses both the economic and environmental dilemmas caused by scrap tires. Using microwave technology, under low heat, RP breaks down long-chain polymers into simpler molecules (gasses) and produces no air, water, or land based pollution or waste. With minimal pre-processing, tires are cleanly broken down into 4 high quality, valuable, market-ready commodities with common industrial or renewable energy applications; a synthetic gas with 30% more BTUs than natural gas; a synthetic oil similar to #2 Diesel with 10% higher BTUs; recycled carbon black (CB)— a major industrial commodity; and recycled steel (from steel belts). Currently a pilot plant processing 900 tires/day (TR900) is operating in Sault Ste. Marie, Ontario. EP/EWI will bring the first commercial sized RP Plant (TR6000 – 6000 tires/day) to Wyandotte, MI. Developed in 3 stages over 2 years, the plant will process 2 million tires/year; making 2MW/Electricity, 8,000 tons/CB; 800,000 gal/oil; and 200 tons/steel.
Enkive, LLC » Information Technology
Enkive, LLC was formed as a spin off from The Linux Box Corp. to commercialize its email archiving and e-discovery software, Enkive. The company is leveraging the latest market enthusiasm for open source software as a way of doing business. Enkive, the software to which the company owns the copyright, is distributed under the GNU Affero General Public License. It has been broadly adopted by over 10,000 organizations worldwide and is attracting a community of developers to help support it and localize it. Enkive is focused on adding to the growing list of innovative features. The company generates funding for this effort by following the Red Hat model and selling support contracts, service level agreements and professional services to a segment of the organizations that are using the software. The company is located in downtown Ann Arbor and expects to double the size of the team to develop new unique features that will increase its market share through various investment channels.
ENRG Power Systems LLC » Advanced Transportation
Headquartered in Grand Rapids, MI – with offices in Detroit and technology development facilities in Long Island, NY – ENRG Power Systems LLC engineers and markets an easy-to-retrofit ignition coil system to reduce fleet vehicle operating expenses. The ENRG Power System® (EPS) improves rear-wheel drive truck and van fuel economy by 14–21%, while reducing their greenhouse gas emissions. Using well-documented, well-proven plasma ignition technology, the EPS reduces fuel use (and operating costs), improving the fleet operator’s bottom line and providing much of the benefit of new hybrid vehicles to a fleet’s in-service work vehicles, at a much lower cost. The EPS is certified for sale in all 50 states, and is well positioned to capitalize on and meet the country’s demand to reduce greenhouse gas emissions and reduce our reliance on imported oil, all at a reasonable price. For the first time, fleet owners can afford to improve their carbon footprint while saving money at the same time, all in a package that can be installed on their current vehicles in about 2 ½ hours. With in-lab and on-road validation in Europe and here in Michigan, EPS LLC has begun its volume expansion.
ENT Biotech Solutions, LLC » Medical Devices
ENT-BT provides a surgical tool tailored to adenoid removal (adenoidectomy). This is an underserved market due to the absence of optimal instrumentation. ENT-BT capitalizes on the trend to perform this procedure in Ambulatory Surgical Centers (ASCs). Physicians own and operate ASCs, seeking to combine efficacy and efficiency. Surgeons are the purchasers who decide upon instruments based on patient care and cost-effectiveness. There is no dominant tool used; they all present drawbacks. ENT-BT provides a surgical tool targeted to particular tonsil tissue, especially adenoid, in a way that combines heat and manual cutting with no suction necessary. This results in an estimated 50% reduction in surgery time, along with fewer surgical complications and less patient discomfort. The device will be fully disposable and is less expensive to purchase than most competitors and overall ends up the most cost effective device when accounting for surgery time and post-operative issues. Market research shows doctors seek a better solution. This device is intuitive and easily mastered. The adenoid removal market will grow based on projected pediatric population growth and medical trends. The first target market is ASCs with clusters of ENT surgeons which captures fast sales ramp up.
HireStarts, LLC » Information Technology
HireStarts LLC is a combination of Facebook and Match.com focused on connecting college students with hiring companies — simplifying the job search and recruiting process. We address the problem of finding, recruiting, and hiring qualified students that will fit company culture. We offer students the ability to find positions nationwide. Students use a video to introduce themselves to companies, something a paper resume does not do. Our service saves employers time and money by streamlining the hiring process. Beta version launched in April, and has grown to over 350 members in the first 3 months. HireStarts also has achieved revenue through resume services to assist students while they prepare for the job market. HireStarts is a startup built by students for students!
Ideomed » Information Technology
Ideomed®’s Abriiz® platform empowers individuals to manage their chronic conditions with an affiliated care team. The tool is sold via group license to insurance companies, who in turn engage their members to achieve better health and cost outcomes. The initial focus of Ideomed® was asthma, the number one US pediatric condition. The added insurer cost of very poorly controlled asthma is $7000 per child per year. Abriiz® helps individuals gain control based on an innovative application of adherence science. The Abriiz® care team web, for the individual’s family members and organizational care managers, is used to set medication schedules, define incentives, and monitor. The mobile application is used by the individual to receive reminders and guidance, log info, and view progress. This solution has reduced ER visits and school absences in trials of Abriiz® Asthma, and several organizations are now using it as paying clients, including Medicaid insurers. Ideomed® has a distinctive and recognized brand, proprietary approach, and copyrighted content with meaningful differentiation. Ideomed® will offer a portfolio of self-management solutions, cross selling to a growing base of organizational clients. The portfolio is currently expanding to include Abriiz® Heart (to reduce heart failure readmissions) and Abriiz® WaiPointes (for Women’s Health).
InfiChem Polymers, LLC » Advanced Materials
InfiChem Polymers, LLC (“the Company”) was formed in 2009 to commercialize its proprietary chemical process for recycling of polyurethane scrap destined for landfills into the InfiGreen™ line of polyol products that are used in production on new polyurethanes. Worldwide, the Company is first to the market with this innovative technology. In today’s market, businesses are seeking to reduce their carbon footprint, improve their “green image,” and cut cost. In response, InfiGreen™ polyols are competitively priced, environmentally friendly materials that are exceptionally well received. From its demonstration facility, the Company already supplies customers in the construction and automotive industries. For its efforts the Company has received numerous awards including Chrysler’s 2010 Environmental Achievement Award, 2011 Accelerate Michigan Innovation Award for Advanced Materials, and 2012 Detroit Free Press Michigan Green Leader Award-Small Business. The company plans to continue with significant expansion of its production capabilities to meet the growing demand for its products. 2012 gross sales are on track to increase 300% compared to previous year, and rapid sales growth is projected as the Company implements its expansion in NAFTA, followed by Europe, Asia, and South America.
InPore Technologies, Inc. » Advanced Materials
InPore Technologies has developed and is bringing to market a platform technology for which there are numerous marketable opportunities. The Company’s primary focus is on the use of its sub-micron particles, trade-named Mezzopore™, as additives for water filtration membrane applications. Industries ranging from municipal drinking supplies to food/beverage production to the manufacturing of microchips and pharmaceuticals require large quantities of very pure water. Due to the constraints of existing technologies, producing this water consumes a great amount of energy. Mezzopore-enhanced filter cartridges can reduce energy consumption by more than half while improving water quality. Our additive is priced to provide end-users with a ROI of greater than 75% while also increasing gross margins for membrane manufacturers. The value proposition offered, coupled with the ever increasing demand for pure water and the significant amount of M&A activity in this sector, suggests that InPore Technologies is a solid investment opportunity.
Interleaved Magnetic Products, LLC » Products and Services
Interleaved Magnetic Products LLC (IMP) is an Ann Arbor-based start-up. IMP’s owns a patent pending design for a new magnetic motor that uses flexible printed circuits (“FPC”), rather than wound wire. The FPC can be formed to operate in a serpentine air gap. The topology firstly uses low-priced ceramic magnets, rather than neodymium magnets; and secondly operates at close to room temperature, greatly reducing heat loses. This means that the motor can change the current cost paradigms while improving efficiency by up to 100% in some applications. The motor is broadly applicable to most products, which use magnetic motors: motor bikes, hybrid electric vehicles, linear actuators, hard-drives and DVD-players, and loudspeakers. IMP’s proof-of-concept was funded by the NSF, through a SBIR grant. IMP is owned and run by a patent attorney, who ran multiple departments, including product engineering and quality, for a Fortune 500 high– tech company. IMP is planning on commercializing its technology through the quickest-to-market opportunity: loudspeakers. IMP’s first product is a successory, allowing cell phone users to have a conference call or listen to high-quality audio with something that requires no power connection and fits in the palm of their hand.
Intrinsic Medical Imaging » Medical Devices
Intrinsic Medical Imaging, LLC, is commercializing Spectrum, a cardiovascular medical imaging platform that provides unprecedented accuracy, ease of use, and image visualization enabling superior diagnostic, planning, and treatment solutions. Spectrum was built on Intrinsic’s Authentic 3DTM technology, which uniquely preserves the integrity of standard computed tomography (CT) data to allow for non-invasive, 360o exploration inside the human body. Spectrum overcomes long-standing challenges in CT image-guided diagnostics, such as the “blooming” effect caused by dense calcification that materially overstates vessel stenosis, leading to over $1B in unnecessary cardiac catheterizations. Thus, it stands to make an immediate impact on the annual costs of heart disease in the U.S., which exceed $360B. Spectrum is currently being tested by cardiovascular clinicians at five major U.S. hospitals with studies focused on the coronary, vascular, and structural heart markets. The flagship product is supported by 10 pending patents and has received 510(k) clearance from the FDA, making it a robust technology with significant growth potential. Intrinsic’s technology has applicability across multiple medical specialties, such as: interventional pulmonology, radiation oncology, orthopedics, otolaryngology, and neurosurgery. Preliminary market feedback also suggests potential future application in industries such as oil and gas, aerospace, homeland security, and drug research.
inventev » Advanced Transportation
inventev is an innovator in Plug-in Hybrid Electric Vehicles (PHEV) for the commercial fleet truck market. The company is creating a unique, lower-cost electric drive system it will install on OEM-branded new trucks to meet the immediate needs of medium duty commercial fleet owners. The company is led by innovative, successful automotive industry veterans who have the knowledge, experience and relationships with key customers and suppliers. The commercial fleet customers are looking to substantially reduce their fuel and maintenance costs while minimizing incremental capital expense. With the soaring costs of fuel, the U.S. dependence on oil imports and a growing desire to reduce greenhouse gas and other emissions, inventev provides a next generation technical solution to a real business need and is NOT just another “electric vehicle startup” company. Based in southeast Michigan, inventev also has a desire to assist in the local support of manufacturing and vehicle technology development. They are interested in partnering with key suppliers, customers, economic development groups and investors to bring their commercial fleet electrification product to focused market segments where the large OEMs traditionally turn to downstream partners.
iQ-Telematics » Advanced Transportation
iQ-Telematics™ is a company driven by innovation and proven visionary leadership in Automotive trends generally and in Driver Distraction Mitigation in particular. Independently, subject matter experts in U.S., EU, and multiple public opinion research1 confirmed our vision, and our solution viability. iQ-Telematics™ was founded in 2009 to commercialize licensed patents owned by the mother company, Applikompt. We have filed additional subjects with the USPTO in 2011 for advanced versions and we are currently testing Pre-Production, (PP0), version of iQ-Gateway™ that we developed with Purdue University-Calumet.
As part of our commitment to Michigan, we identified a manufacturer for our products in Michigan. The strength of our product is in treating the entire Driving Experience from a human interest perspective and not from a technology or gadgetry perspective. We rely on proven, simple, and “reliable” technologies that do not require drivers to look away from the road or remove any hand from the wheel to activate phones or other built in equipment. These developed technologies come under three headings, Hands On Wheel Interface™, IntelligentNotification™ and IntelligentAssistant™.
Jiva Pharma, Inc. » Life Science
Jiva Pharma, Inc. is an Ann Arbor-based, Drug Development Company, founded in 2007. It has created dietary supplements that deliver digestive and immune health benefits addressing a large, worldwide market need. Its lead product JP-005 is a proprietary formulation of concentrated prunes with prebiotics, which are non-digestible oligosaccharides that promote the growth of beneficial bifidobacteria and lactobacilli, in the colon for greater efficacy as a laxative, and improve colon health. All ingredients are natural, recognized as safe (GRAS) by the FDA for use in food. The formulation is pleasant tasting, and may be used daily over months. JP-005 in a liquid pouch, 50 gm, is in preproduction trial packings. It is reconstituted by stirring in water, tea, coffee, or juice etc. Trademark SpoonO’Prune™ has been allowed by USPTO. JP-007 and JP-008, are proprietary formulations of calcium sennosides with prebiotics. These are for nighttime use for hard-to-treat constipation, not recommended for more than a week at a time. JP-007 is in the form of gummies, and JP-008 is as chocolates. These products would compete with existing products such as Senokot™ or Prunelax™ for greater efficacy and taste.
KashPile » Information Technology
KashPile is a money management site that helps parents teach their kids to earn, save and spend responsibly. Parents can use KashPile to set an allowance, assign chores and specify a spending budget for their kids. Kids can use KashPile to view their account balance, create savings goals, and engage in a safe online shopping experience powered by Amazon.com®. KashPile is designed to capture all the sources and uses of a child’s savings. This level of detail provides kids with an undistorted view of their finances, in turn helping them prioritize the items they need over the items they want. KashPile isn’t just for parents and their children. One of the core features of KashPile is that it allows parents to connect with their family and friends. Approved family and friends are then able to send financial gifts to a child via PayPal® directly toward a child’s KashPile goals. KashPile is completely free to use for families! KashPile currently earns a commission for sales referred to Amazon.com®. In the long-term KashPile will consider other monetization options; however, the current focus is on creating a fun and safe user experience to rapidly scale the community of KashPile families.
LED Optical Solutions » Alternative Energy
LED Optical Solutions, LLC, (aka LEDOS), is a Michigan based “start-up” founded in 2008 to provide engineering, development and design services to the commercial lighting industry. LEDOS knows and understands light and how to develop lighting products using LED’s that generate light. LED lighting is a disruptive technology shifting users away from filament bulb technology with the promise of energy savings, environmental consciousness and long product life. As engineers, quality and marketing personnel, we garnered over 26 years of experience while employed in the automotive lighting industry. We remain on the cutting edge of LED lighting design and development, this team is uniquely positioned to transition acquired skills and experience into a new company. LEDOS began generating commissions by providing engineering and design services for various customers. In the past 3 years, we have evolved to include product sales of LED light engines and other lighting components. LEDOS has now self commissioned proprietary “Powered by LEDOS” brand products. Our current focus is the commercialization of the Hyperion LED Bulb targeted for the niche commercial lighting market. LEDOS will be marketing a 10, 18 or 28 LED count product producing different levels of light output and energy savings.
Micro-Laser Assisted Machining Technologies, LLC » Next Generation Manufacturing
The USA’s $90B industry of high precision ceramic and semiconductor fabricators has been challenged with the high cost of machining and low production rates for existing industrial manufacturing processes. These cost and productivity problems associated with machining advanced ceramics, electronics, and optical materials are excessive tool cost, low material removal rates (MRR), poor surface finish and subsurface cracks requiring post-process polishing operations. The breakthrough patent pending µ-LAM technology developed by Dr. John Patten and Dr. Deepak Ravindra at Western Michigan University is a diamond-cutting tool coupled to a high intensity laser. The laser beam energy provides a localized heat source, focused at the cutting zone beneath the tool, sufficient to thermally heat and soften the work piece material during contact with the tool. This laser induced heating and softening of the tool/work piece interface reduces the cutting zone’s hardness during material. The reduced work piece hardness also reduces the tool wear rate and increases productivity as the cutting speed and feed increases. The benefit from the utilization of µ-LAM’s patented precision ceramic/semiconductor machining technology is reduced manufacturing costs, increased throughput, improved surface finish and an increased competitive advantage to precision ceramic and semiconductor component fabricators.
Midwest Flare Recovery, Inc. » Alternative Energy
www.midwestflarerecovery.com (Currently under construction)
Midwest Flare Recovery, Inc. is a Michigan corporation located in Novi, and was founded in 2009 by Norman J. Nazaroff and Thomas D. Vandeveer. The company seeks to reclaim gaseous hydrocarbons emitted at the wellhead as a byproduct of oil production. These gases are converted to saleable liquefied products or used for energy production maximizing energy production while reducing wasteful and polluting carbon emissions. A specialized machine to perform the reclamation was designed, built and field tested in two locations during 2009. However, field operations were halted while efforts to secure additional operating capital at the time were unsuccessful. Daily operations have been on hold since, as additional financing is sought. Midwest plans to locate an R&D and production facility in Michigan, seeking to hire approximately 50 employees over three years. Plans also include the location of product collection and aggregation facilities in Illinois and Pennsylvania, with later expansion to other Midwest locations.
Monarch Antenna »Next Generation Manufacturing
Monarch Antenna is the leader in smart adaptive antennas for wearable, conformal and Smartphone applications. Monarch’s performance advantage is based on the Company’s patented self-structuring antenna architecture. This proprietary antenna architecture continuously monitors the signal level and dynamically adapts to restore the optimal RF communication link. Key benefits include a dramatic increase in gain and the real-time tuning of the frequency, the beam form and the input impedance. Monarch’s antenna products can be delivered on a wide variety of substrates including glass, high frequency laminates, and eFibers that can be sewn into a uniform. Monarch Antenna’s headquarters are located in Ann Arbor, MI, USA.
Munetrix, LLC » Information Technology
Munetrix is a comprehensive suite of financial reporting, management and forecasting tools designed specifically to meet the needs of local units of government and schools. Recognizing the need for these institutions to anticipate, study, predict and report on fiscal results, this web-based management tool helps public institutions better understand and communicate their financials with stakeholders, and plan using predictive analysis. Subscribers can build long-term forecasts and run scenarios in a fraction of the time over legacy systems. Assumptions run against industry vetted algorithms and metrics, which provide clear visibility to future budget impacts; allowing valuable time for course correction if needed. The output is digestible even to the non-financially inclined. Data is presented in a consistent, normalized manner that is meaningful and in context. A socially networked platform, licensed Munetrix users benefit from the system’s architecture that allows network building to facilitate real-time information and best practice sharing. They are able to communicate other financial managers from within the system; compare departmental or overall performance against others; and post success stories in a dynamically, searchable forum. Munetrix is launched in Michigan with 94 customers and is in the early stages of systematically executing its growth strategy into other states.
nanoMAG LLC » Advanced Materials
nanoMAG LLC, a revenue stage engineered biomaterials manufacturer, is developing and commercializing next generation, high strength, lightweight nanomagnesium biocompatible materials with applications in orthopedic medicine. nanoMAG develops biomedical pins, screws and fixtures, and sells the finished part or set to an OEM such as Stryker, Synthes, Biomet and others. An OEM partner’s product design is manufactured by nanoMAG. The OEM completes sterilization, packaging, and then handles worldwide sales, marketing and distribution of the finished products. For biomedical implants, our gross margins are 80+%. Orthopedic surgeons and patients want to reduce secondary surgeries needed to remove a pin or plate once the bone heals. The current bioabsorbable plastics lack sufficient strength and stiffness during the healing process; existing metal parts are strong but not bioabsorbable. Our new BioMg® alloys are strong like bone but degrade over time to provide nutrients to promote bone re-growth. Building on the 20 year success of Thixomat, a pioneer in light weight magnesium alloys, nanoMAG is focused on the biomedical opportunities: building braces for Donjoy, surgical instruments and biomedical implants for our OEMs. A strong board of advisors, all of whom have extensive industry experience, complements our team of veteran Materials Scientists and Business Developers.
NextCAT, Inc. » Alternative Energy
NextCAT is commercializing a class of patent pending heterogeneous catalysts for biodiesel production that will enable cost efficient processing of significantly lower priced feedstocks like residual corn oil, waste vegetable oil and brown grease. Our long term goal is to expand its product portfolio to include heterogeneous catalyst for the renewable fuel market utilizing the same low-cost feedstocks. NextCAT has uncovered a new class of biodiesel production catalysts that have the ability to convert less refined and less costly oil feedstocks to biodiesel while, at the same time, simplify the biodiesel production process. With regard to feedstocks, benchmark and pilot reactor research indicates that our new generation of catalysts can convert oil feedstocks with FFA as high as 30% and water up to 5% with a >98% FAME yield. While developing this technology, NextCAT has raised over $1.5 million including NSF Phase I and IB SBIR awards in 2010 and most recent NSF Phase II SBIR award for the design and build of a fixed bed, single stage reactor pilot demonstration. Through the design, optimization and build of a pilot reactor, NextCAT is in the process of demonstrating the catalyst performance at a larger scale.
Nutriinfo.com » Information Technology
Minu Interactive Inc. (dba: Nutriinfo.com) is an online health solution company in Ann Arbor, Michigan. We offer software solutions to corporations to improve and sustain health of their employees or customers. Our wellness platform WATTTM (Wellness Anytime Through TechnologyTM) is targeted to reduce health risk in employees and individuals suffering from obesity and other chronic diseases. The online platform has innovative tools designed to engage individuals with health providers and nutritionists to motivate them to lose weight while taking control of their health by tracking their food and exercise, getting personalized advice from the expert, monitoring health indicators and behavior modification. Our software is integrated with the interface for health providers to access client data, monitor progress, measure results, and provide real time advice and guidance. Nutriinfo.com, a B2B2c company has customized and licensed the cost-effective online WATTTM platform to corporations and health providers as a population health management tool with high employee engagement. Nutriinfo’s team consists of the Founder and CEO, Mia Jang, the VP of Marketing & Sales, Bhramara Tirupati and experts in nutrition and technology as well as health and wellness industry experts including advisory board members, Ted Dacko, Dr. Michael O’Donnell, Michael Samuelson, and Kurt Riegger.
NXT GEN LED » Alternative Energy
With increasing demand for energy while reducing global warming, NXTGEN LED plays vital role reducing energy consumption and CO2 emissions one streetlight at a time. Our vision is to replace the traditional (poisonous) mercury vapor lamp with our LED Thermal Management Kit (TMK). The streetlight LED Thermal Management Kit, with a 100-watt solid state LED, produces the same volume of light as a 400w metal halide lamp. The TMK has two main competitive advantages: First, the TMK is a patent pending solution for the LED heat dissipation is the key to the electricity savings and sales, allowing the use of a single LED chip to produce an unprecedented volume of light. All other competitors use hundreds of miniature LEDs with lower light output. Second, the TMK can be produced either as a low cost retrofit of existing streetlights, or as complete new model replacement.
ONL Therapeutics, LLC » Life Science
ONL Therapeutics (ONL) is ophthalmic pharmaceuticals R&D Company developing therapeutics to prevent vision loss due to retinal disorders by inhibiting photoreceptor death. This approach is novel and complements existing therapeutic and surgical treatments of age-related macular degeneration, diabetic retinopathy, and retinal detachment. ONL’s products have multibillion-dollar sales potential due to unmet medical need and growing patient populations. ONL’s products are currently in preclinical development stage with retinal detachment, an acute, orphan indication as a rapid, low-cost, and low-risk path to clinical proof-of-concept. ONL is able to operate in highly cost-efficient manner with company labs inside a larger pharmaceutical development facility. Cost of development to exit is $7.5 million, funded by current and future government grants and future angel/venture capital rounds. Company has a management team with deep ophthalmic pharmaceutical development and commercialization expertise, as well as an internationally renowned Scientific Advisory Board. ONL Therapeutics has secured rights to patents protecting methods and compounds. Upon reaching human proof-of-concept stage in 2015 ONL will exit via company sale to a larger pharma company. Comparable exits have been $50–200 million deals with milestones and royalties.
Ornicept » Alternative Energy
Ornicept automates bird monitoring and puts unprecedented data in the hands of decision makers. For wind energy developers, military natural resource managers, regulators, and airfield controllers, having up-to-date information on bird movement is mission critical. Through a state-of-the-art network of distributed cameras, computers, and computer vision algorithms, Ornicept has developed a system for remotely collecting data on birds by species as they move through a survey zone. For protected species such as California Condors, Whooping Cranes, Bald Eagles, or Golden Eagles, wind energy developers need to have a comprehensive understanding of their prevalence for successful permitting and project operation. For airfield managers, threats often manifest themselves as common waterfowl such as geese or ducks. For these and other applications, collecting the necessary data has previously relied on deploying teams of biologists to sit with binoculars, a costly and inefficient solution. Leading the way to the future of avian monitoring, the Ornicept system offers dawn-to-dusk monitoring year-round and puts high-quality data in the hands of biologists and decision makers. As a partner in development and environmental management, Ornicept delivers cutting-edge solutions for digital avian surveying.
Patient Provider Communications » Life Science
Patient Provider Communications, Inc. is an early-stage, Ann Arbor-based, healthcare technology company with a patented nurse call solution, EloquenceTM. This system improves nurse call technology by providing better in-hospital communication, saving time and money, and leading to better patient outcomes. Current nurse call systems rely on a manual triage process which increases the risk of harm to patients by causing significant delays and missed care, wasting over $12B annually in the US alone. These systems also fail to allow non-English speaking patients the ability to request their needs, impacting patient in over 80% of US hospitals. With the intensive integrated role of nurses in hospitals today and with the staggering rates of errors and avoidable adverse events, hospitals cannot continue requiring nursing personnel to manually triage nurse call systems. The Eloquence prototype, consisting of an advanced pillow speaker, nursing hand held device, and a web-based dashboard, is built using a patented automated triage process that has outperformed existing nurse call systems in both nurse and patient user assessments in an NIH funded study. By offering a marked improvement over other product lines, including multilingual functionality, Eloquence can significantly increase nurse call system market share, making PPC highly desirable for acquisition.
Phenometrics Inc. » Life Science
Phenometrics is a Lansing, Michigan-based emerging plant science instrumentation manufacturer, which produces innovative measurement tools for the algae and food science industries. Phenometrics’ flagship product is an environmental photo bioreactor (ePBR) used to grow algae under controlled conditions using automatic measurement tools to measure algae growth and other factors. Phenometrics already has sales and is shipping products worldwide. The ePBR has quickly become the standard research platform for scientists worldwide who are studying specific algae for oil production. This oil, called green crude, can be converted into biofuel as a renewable source of biodiesel for airplanes, ships and trucks. This same oil and the algae biomass can be used for food consumption, targeting the needs of the nutraceuticals and algae food marketplace. Phenometrics looks to the future with a brand new technology product currently under development that addresses the needs of the agricultural food marketplace, and is already in demand by companies that cultivate seeds, manufacture fertilizers and pesticides worldwide. Phenometrics is a technology transfer spin-out company from Michigan State University where its technology and products were developed by biologists and engineers in the Kramer Lab, as part of the Department of Energy’s Plant Research Laboratories.
Poligan Peptides, LLC » Life Science
Poligan Peptides is a Michigan based LLC located in the Michigan Life Science and Innovation Center. The company’s goal is to bring unique peptide compositions to market that alter the body’s immune response when it is not performing properly. The company will produce products with peptide compositions that will help remove hydroxyl free radicals that are absorbed during radiation exposure. The recent Fukushima Dai-ichi incident has left millions of people in and around Japan with free radicals in their systems. They do not currently have a suitable method of dealing with the aftereffects on their health and have been limited to drugs that were originally designed for different uses. The company has developed an all-natural and completely non-toxic peptide composition that exerts anti-oxidative and anti-radiation effects at a very reasonable cost. Our peptide composition will fill a much need void in the emerging billion dollar industry of radiation exposure products.
Protean » Products and Services
Protean, a startup based out of Ann Arbor, MI, is developing a stylish, minimalistic, and reprogrammable card called Echo. Echo is one card to rule them all; it can mimic every card in a consumer’s wallet. By consolidating a consumer’s plastic collection into a single card, Echo eliminates wallet clutter. Echo users can securely and conveniently carry an unlimited number of cards and therefore need never again miss out on opportunities to earn discounts and reward points via in-store and loyalty cards. Echo also syncs wirelessly with Protean’s mobile wallet app (iOS/Android), enabling Protean to deliver the first mobile wallet that can be used everywhere payment cards are accepted. This wallet provides merchants with an unprecedented opportunity to create a more engaging in-store customer experience and to incentivize the use of in-store cards. When customers use in-store cards, merchants save on hefty transaction fees and collect more detailed customer data. For consumers, Protean’s wallet app will facilitate better and faster purchasing and financing decisions, saving them time and money.
RecoveryPark » Products and Services
RecoveryPark is an independent, 501©(3) nonprofit organization established in 2010 to help revitalize Detroit through innovative job creation projects benefitting those persons and communities in recovery. Our strategy is to establish an integrated, self-sustaining cluster of food related businesses by leveraging Detroit’s large available workforce, abundant open space, access to fresh water, extensive built infrastructure, access to technical support services and private and public capital investments. RecoveryPark collaborates with over 100 community partners in the design and implementation of these projects. A robust aquaculture industry will create thousands of jobs in hatcheries, production facilities and processing plants as well as additional opportunities in related industries. AquaNourish Farms is a for-profit company. It will be our flagship project. It will be the largest indoor facility in the country, built on fifteen years of aquaculture experience. As a closed loop, state-of-the-art venture, it will combine recirculating aquaculture, aquaponics, algae production and bio-energy. Fresh, local and live Tilapia has an explosive economic potential in Michigan. A significant consumer base is demanding locally sourced food grown in sanitary conditions. Foreign imports are decreasing rapidly due to increasing internal demand. Transportation costs are rising and consumers are increasingly dissatisfied with the frozen products currently available.
Retia Medical » Medical Devices
Retia Medical makes monitors for high-risk patients in the operating room and intensive care units. Clinicians use Retia’s cardiac output monitor to make earlier diagnoses and optimize treatment for patients with conditions such as hemorrhage, heart failure, and sepsis. More than 32 independently conducted studies have shown that optimized hemodynamic management with accurate CO monitoring can lead to significantly improved outcomes and lower costs. Among less-invasive devices, Retia’s monitor maintains its accuracy when the patient goes unstable, which is when other devices fail. Retia will target its first product for the $2+ billion hospital market, which includes at least 15 MM high-risk surgeries and 3 MM ICU patients. Retia has protected its technology, developed at Michigan State and MIT, with ten patents. It has also validated the technology through extensive tests in animals and over 300 humans. Retia has raised seed capital to finance product development and further clinical studies. With the support of a strong advisory board comprised of industry and clinical experts, the team expects to receive FDA approval and launch the product within 2.5 years.
Supported Intelligence, LLC » Information Technology
Supported Intelligence (SI) has developed the Rapid Recursive Model™ (patent pending) to significantly improve the way valuation and risk assessment decisions are made. For decades, businesses and individuals have struggled to use traditional decision models to evaluate investments under changing conditions. The Rapid Recursive Model™ will revolutionize the way investment decisions under conditions of uncertainty will be made in the future. SI will offer the Rapid Recursive™ (“RR”) software as a desktop installation, SaaS subscription, and in solution-targeted mobile versions. Revenues will be generated through licensing and subscription, maintenance contracts, data subscriptions, and custom configuration services. The base of potential users includes any organization or individual that makes investment decisions involving options arising over time. We see immediate opportunities in finance, venture capital, insurance, oil & gas, real estate, manufacturing, health care, defense, and other industries. SI is an offshoot from Anderson Economic Group, LLC (AEG). After years of product development under the AEG umbrella, we announced the formation of the company and the forthcoming product in July 2012. We have received positive feedback, follow-on press and numerous customer inquiries. AEG continues to be an active partner in the development and marketing of the product.
TigerLAB » Medical Devices
TigerLAB is an early stage respiratory device company based in West Michigan. TigerLAB develops and commercializes innovative respiratory products that lower healthcare organization costs while improving patient experiences and outcomes. In 2012, TigerLAB launched the Oxygen Flow Diverter, their first FDA-approved respiratory device, into the market. Commercialization efforts for the Diverter are on-going, paving the way for a pipeline of respiratory devices. Their second internally-developed respiratory device is expected to be available for sale in early 2015. Beyond 2015, TigerLAB aspires to continue the growth of their respiratory device line, contributing further innovation to the industry and the medical device reputation of the West Michigan region.